MX2020007906A - Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. - Google Patents

Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.

Info

Publication number
MX2020007906A
MX2020007906A MX2020007906A MX2020007906A MX2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A MX 2020007906 A MX2020007906 A MX 2020007906A
Authority
MX
Mexico
Prior art keywords
otitis
prevention
treatment
composition
upper respiratory
Prior art date
Application number
MX2020007906A
Other languages
English (en)
Inventor
Quintana Esther Antonia Jiménez
Gómez Juan Miguel Rodríguez
Original Assignee
Probisearch S L U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probisearch S L U filed Critical Probisearch S L U
Publication of MX2020007906A publication Critical patent/MX2020007906A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/181—Salivarius
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Una cepa de Lactobacillus salivarius como producto probiótico, y su uso en el tratamiento y/o la prevención de otitis e infecciones respiratorias de vías altas.
MX2020007906A 2018-01-26 2019-01-25 Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas. MX2020007906A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382046.3A EP3517119B1 (en) 2018-01-26 2018-01-26 Composition comprising new lactobacillus salivarius strain and method for the prevention and treatment of otitis and upper respiratory infections
PCT/EP2019/051858 WO2019145476A1 (en) 2018-01-26 2019-01-25 Composition comprising new lactobacillus salivarius strains and method for the prevention and treatment of otitis and upper respiratory infections

Publications (1)

Publication Number Publication Date
MX2020007906A true MX2020007906A (es) 2020-10-28

Family

ID=61189392

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020007906A MX2020007906A (es) 2018-01-26 2019-01-25 Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.

Country Status (15)

Country Link
US (2) US11406674B2 (es)
EP (1) EP3517119B1 (es)
JP (1) JP2021511822A (es)
AU (1) AU2019211073B2 (es)
BR (1) BR112020015168A2 (es)
CA (1) CA3089366A1 (es)
CL (1) CL2020001958A1 (es)
CO (1) CO2020009424A2 (es)
DK (1) DK3517119T3 (es)
ES (1) ES2898876T3 (es)
MX (1) MX2020007906A (es)
PE (1) PE20210319A1 (es)
PT (1) PT3517119T (es)
RU (1) RU2020125713A (es)
WO (1) WO2019145476A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3781183B1 (en) * 2018-04-20 2025-03-19 Institut national de la santé et de la recherche médicale (INSERM) Treating pseudomonas aeruginosa respiratory tract infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA99007378A (es) 1997-02-11 2005-04-19 Entpr Ireland Cepas probioticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de lasmismas.
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
SI1312667T1 (sl) 2000-08-25 2009-04-30 Wakamoto Pharma Co Ltd Probiotiäśni produkti, ki vsebujejo sev l. salivarius
RU2302458C2 (ru) 2001-07-26 2007-07-10 Элиментери Хелс Лимитед Пробиотический штамм lactobacillus salivarius (варианты), пробиотический препарат на их основе и способ лечения или предупреждения с использованием штаммов lactobacillus salivarius
PE20030274A1 (es) 2001-07-26 2003-05-08 Alimentary Health Ltd Cepas de lactobacillus salivarius
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
AU2007260074B2 (en) * 2006-06-13 2011-12-08 Nestec S.A. Prevention and treatment of otitis media with non-pathogenic bacterial strains
KR101098946B1 (ko) 2009-07-22 2011-12-28 대한민국 신규한 락토바실러스 살리바리우스 균주 및 이를 함유하는 사료첨가제 조성물
CN102618452B (zh) 2011-02-01 2014-06-25 任发政 唾液乳杆菌及其代谢物的制备方法和组合物以及应用
US9403181B2 (en) * 2013-07-26 2016-08-02 Paul O'Malley Oral care product formulation
WO2015093937A1 (en) 2013-12-19 2015-06-25 N.V. Nutricia Lactobacillus salivarius for the treatment of mastitis
CN104095224A (zh) * 2014-06-11 2014-10-15 胡安然 一种防治中耳炎的微生态特殊膳食
WO2016077190A1 (en) 2014-11-10 2016-05-19 National Institutes Of Health Probiotic therapeutic applications

Also Published As

Publication number Publication date
BR112020015168A2 (pt) 2020-12-29
PE20210319A1 (es) 2021-02-16
PT3517119T (pt) 2021-11-30
WO2019145476A1 (en) 2019-08-01
US20210030820A1 (en) 2021-02-04
DK3517119T3 (da) 2021-11-15
US11903983B2 (en) 2024-02-20
CL2020001958A1 (es) 2020-12-11
ES2898876T3 (es) 2022-03-09
EP3517119A1 (en) 2019-07-31
AU2019211073B2 (en) 2025-01-30
CO2020009424A2 (es) 2020-10-30
JP2021511822A (ja) 2021-05-13
EP3517119B1 (en) 2021-08-11
US20220347240A1 (en) 2022-11-03
CA3089366A1 (en) 2019-08-01
WO2019145476A8 (en) 2020-10-01
US11406674B2 (en) 2022-08-09
RU2020125713A (ru) 2022-02-28
AU2019211073A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
EP4086334A4 (en) LACTOBACILLUS FERMENTUM STRAIN AND COMPOSITION THEREOF FOR PREVENTING OR TREATING METABOLIC DISEASES
IL291460A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
MY186217A (en) Mixture of hmos
NZ777234A (en) Compositions comprising bacterial strains
EP4293033A3 (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides
SG10201910740UA (en) Lactobacillus fermentum gkf3, composition comprising the strain and method for improving psychataxia using the same
PH12019502340A1 (en) Probiotic molecules for reducing pathogen virulence
PT3412766T (pt) Estirpe lactobacillus salivarius, composição que compreende a mesma e suas utilizações
PL4031157T3 (pl) Szczepy bakteryjne, ich kompozycje i ich zastosowanie w leczeniu zaburzeń żołądkowo-jelitowych
MY193248A (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
EP4086335A4 (en) LACTOBACILLUS FERMENTUM STRAIN, AND COMPOSITION FOR THE PREVENTION OR TREATMENT OF METABOLIC DISEASES, INCLUDING THE SAME
PH12017502042A1 (en) Dietary supplement
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
EP3641568C0 (en) Composition with bacterial strains of the genus Lactobacillus salivarius for the treatment of Parkinson's disease
WO2018135843A3 (ko) 탈모 예방, 발모 촉진 또는 성기능 개선능이 있는 락토바실러스 퍼멘텀 균주 및 이를 포함하는 조성물
EP3757207A4 (en) Bifidobacterium lungum rapo strain for alleviation, prevention, or treatment of rheumatoid arthritis and composition comprising same
MX2020007946A (es) Un producto de combinacion para profilaxis y tratamiento de sindrome de intestino irritable.
PH12019500264A1 (en) Lactobacillus salivarius cjls1511, animal feed additive composition comprising same bacterium or dead cells thereof, and method for producing same dead cells
MY197917A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MY195253A (en) Methods for Celiac Disease Using Lactobacillus Strains
SG11202000113QA (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof
WO2018004224A3 (ko) 신규 스포리치아과 미생물 및 그의 용도